These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10587703)

  • 21. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas.
    Labuhn M; Jones G; Speel EJ; Maier D; Zweifel C; Gratzl O; Van Meir EG; Hegi ME; Merlo A
    Oncogene; 2001 Mar; 20(9):1103-9. PubMed ID: 11314047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment and partial characterization of five malignant glioma cell lines.
    Zhang L; Yamane T; Satoh E; Amagasaki K; Kawataki T; Asahara T; Furuya K; Nukui H; Naganuma H
    Neuropathology; 2005 Jun; 25(2):136-43. PubMed ID: 15875906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
    Kaulich K; Blaschke B; Nümann A; von Deimling A; Wiestler OD; Weber RG; Reifenberger G
    J Neuropathol Exp Neurol; 2002 Dec; 61(12):1092-9. PubMed ID: 12484572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the P53, RB/D13S25, and P16 tumor suppressor genes in marginal zone B-cell lymphoma: An interphase fluorescence in situ hybridization study.
    Dierlamm J; Stefanova M; Wlodarska I; Hinz K; Maes B; Michaux L; Stul M; Verhoef G; Thomas J; De Wolf-Peeters C; Van den Berghe H; Hossfeld DK; Hagemeijer A
    Cancer Genet Cytogenet; 2000 Jul; 120(1):1-5. PubMed ID: 10913669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
    Kovar H; Jug G; Aryee DN; Zoubek A; Ambros P; Gruber B; Windhager R; Gadner H
    Oncogene; 1997 Oct; 15(18):2225-32. PubMed ID: 9393981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
    Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
    Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas.
    Pérez de Castro IP; Malumbres M; Santos J; Pellicer A; Fernández-Piqueras J
    Carcinogenesis; 1999 Sep; 20(9):1675-82. PubMed ID: 10469610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas.
    Ghazizadeh M; Jin E; Shimizu H; Fujiwara M; Arai S; Ohaki Y; Takemura T; Kawanami O
    Respiration; 2005; 72(1):68-73. PubMed ID: 15753637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas.
    Saxena A; Robertson JT; Ali IU
    Oncogene; 1996 Aug; 13(3):661-4. PubMed ID: 8760309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines.
    He J; Olson JJ; James CD
    Cancer Res; 1995 Nov; 55(21):4833-6. PubMed ID: 7585516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas.
    Horbinski C; Nikiforova MN; Hagenkord JM; Hamilton RL; Pollack IF
    Neuro Oncol; 2012 Jun; 14(6):777-89. PubMed ID: 22492957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma.
    Halvorsen OJ; Høstmark J; Haukaas S; Høisaeter PA; Akslen LA
    Cancer; 2000 Jan; 88(2):416-24. PubMed ID: 10640976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes.
    Holland EC; Hively WP; Gallo V; Varmus HE
    Genes Dev; 1998 Dec; 12(23):3644-9. PubMed ID: 9851971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations of TP53, amplification of EGFR, MDM2 and CDK4, and deletions of CDKN2A in malignant astrocytomas.
    Biernat W; Debiec-Rychter M; Liberski PP
    Pol J Pathol; 1998; 49(4):267-71. PubMed ID: 10323080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma.
    Zhao P; Hu YC; Talbot IC
    World J Gastroenterol; 2003 Oct; 9(10):2202-6. PubMed ID: 14562378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Methylation and expression analysis of p16(INK4a) and RB genes in meningiomas].
    Chen MN; Mao Q; Liu YH; Mao BY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):277-9. PubMed ID: 15192837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent progress in molecular mechanisms of leukemogenesis: the cyclin-dependent kinase 4-inhibitor gene in human leukemias.
    Hirai H; Ogawa S; Hangaishi A; Takahashi T; Kurokawa M; Mitani K; Ueda R; Yazaki Y
    Leukemia; 1997 Apr; 11 Suppl 3():358-60. PubMed ID: 9209389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.